Hybrigenics SA
Provider of technologies for studying molecular interactions and antibody selection.
ALHYG | PA
Overview
Corporate Details
- ISIN(s):
- FR0004153930
- LEI:
- 9695003KQD0XMJYDX764
- Country:
- France
- Address:
- 850 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
Description
Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-06-28 19:00 |
Assemblée Générale d'Hybrigenics : point d'activité et approbation de toute…
|
French | 162.7 KB | ||
| 2016-04-25 19:30 |
Hybrigenics : résultats annuels 2015
|
French | 254.6 KB | ||
| 2016-04-04 19:00 |
Hybrigenics renforce la propriété intellectuelle de l'inécalcitol aux Etats-Uni…
|
French | 227.6 KB | ||
| 2016-01-11 18:20 |
Hybrigenics reçoit le feu vert de la FDA pour l'étude clinique de Phase II de l…
|
French | 257.5 KB | ||
| 2015-12-14 18:00 |
Hybrigenics reçoit un feu vert pour une étude clinique de Phase II de l'inécalc…
|
French | 256.4 KB | ||
| 2015-11-19 08:00 |
Hybrigenics présentera de nouveaux résultats in vitro sur l'inécalcitol dans la…
|
French | 268.4 KB | ||
| 2015-11-16 08:00 |
Hybrigenics réunit un comité d'experts internationaux pour le développement cli…
|
French | 149.5 KB | ||
| 2015-10-19 09:00 |
Hybrigenics : résultats et faits marquants du premier semestre 2015
|
French | 219.7 KB | ||
| 2015-07-27 18:45 |
Hybrigenics : revenus et trésorerie du 1er semestre 2015
|
French | 168.8 KB | ||
| 2015-06-22 09:00 |
L'Agence Européenne du Médicament rend un avis favorable à la désignation de l'…
|
English | 150.5 KB | ||
| 2015-05-29 09:00 |
Hybrigenics présente de nouveaux résultats in vitro sur l'inécalcitol dans le c…
|
French | 176.1 KB | ||
| 2015-04-28 19:00 |
Un projet commun entre PicoSeq, Hybrigenics, l'ecole Normale Supérieure et le C…
|
French | 155.9 KB | ||
| 2015-04-27 09:00 |
Hybrigenics : résultats annuels 2014
|
French | 155.2 KB | ||
| 2015-04-20 09:00 |
Hybrigenics présente de nouveaux résultats in vitro sur l'inécalcitol dans la l…
|
French | 179.1 KB | ||
| 2015-04-07 19:30 |
Hybrigenics lève un total de 9 millions d'euros
|
French | 301.4 KB |
Automate Your Workflow. Get a real-time feed of all Hybrigenics SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hybrigenics SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hybrigenics SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
